Back to top
Read MoreHide Full Article
  • Shares Barracuda Networks, Inc. (CUDA - Free Report) gained 0.04% after posting second quarter 2018 revenues of $94 million, surpassing the Zacks Consensus Estimate of $93 million
  • Merck & Co., Inc.’s (MRK - Free Report) shares gained 0.2% after the company purchased a 9.9% stake in KalVista Pharmaceuticals Inc.  at a price of $8.50 per share
  • AnaptysBio, Inc.’s (ANAB - Free Report) shares rallied 101.2% after the company announced positive results and proof-of-concept data from Phase 2a trial of it drug ANB020 In used for the treatment atopic dermatitis
  • Shares of Hudson Technologies Inc. (HDSN - Free Report) declined 0.8% after the company lowered its third quarter 2017 earnings guidance to $0.03-$0.05 a share from $0.10 per share earlier


More from Zacks Corporate Summary

You May Like